Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.

Anushiravani A, Haddadi N, Pourfarmanbar M, Mohammadkarimi V.

Eur J Gastroenterol Hepatol. 2019 May;31(5):613-617. doi: 10.1097/MEG.0000000000001369.

PMID:
30920975
2.

Milk Thistle Treatment for Children and Adults with Trichotillomania: A Double-Blind, Placebo-Controlled, Crossover Negative Study.

Grant JE, Redden SA, Chamberlain SR.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):129-134. doi: 10.1097/JCP.0000000000001005.

PMID:
30694881
3.

Superior silybin bioavailability of silybin-phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers.

Méndez-Sánchez N, Dibildox-Martinez M, Sosa-Noguera J, Sánchez-Medal R, Flores-Murrieta FJ.

BMC Pharmacol Toxicol. 2019 Jan 11;20(1):5. doi: 10.1186/s40360-018-0280-8. Erratum in: BMC Pharmacol Toxicol. 2019 Feb 22;20(1):14.

4.

Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial.

Karbasforooshan H, Hosseini S, Elyasi S, Fani Pakdel A, Karimi G.

Phytother Res. 2019 Feb;33(2):379-386. doi: 10.1002/ptr.6231. Epub 2018 Nov 27.

PMID:
30479044
5.

Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial.

Ebrahimpour-Koujan S, Gargari BP, Mobasseri M, Valizadeh H, Asghari-Jafarabadi M.

Phytomedicine. 2018 May 15;44:39-44. doi: 10.1016/j.phymed.2018.03.050. Epub 2018 Mar 19.

PMID:
29895491
6.

Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.

Li WY, Yu G, Hogan RM, Mohandas R, Frye RF, Gumpricht E, Markowitz JS.

Clin Ther. 2018 Jan;40(1):103-113.e1. doi: 10.1016/j.clinthera.2017.11.013. Epub 2017 Dec 19.

7.

Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial.

Darvishi-Khezri H, Salehifar E, Kosaryan M, Karami H, Mahdavi M, Alipour A, Aliasgharian A.

Phytother Res. 2018 Mar;32(3):496-503. doi: 10.1002/ptr.5995. Epub 2017 Dec 13.

PMID:
29235162
8.

Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.

Khalili N, Fereydoonzadeh R, Mohtashami R, Mehrzadi S, Heydari M, Huseini HF.

J Evid Based Complementary Altern Med. 2017 Oct;22(4):603-608. doi: 10.1177/2156587217696929. Epub 2017 Mar 21.

9.

The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial.

Darvishi-Khezri H, Salehifar E, Kosaryan M, Karami H, Alipour A, Shaki F, Aliasgharian A.

Complement Ther Med. 2017 Dec;35:25-32. doi: 10.1016/j.ctim.2017.08.007. Epub 2017 Aug 24.

PMID:
29154063
10.

The Long-Term Efficacy of a Galactagogue Containing Sylimarin-Phosphatidylserine and Galega on Milk Production of Mothers of Preterm Infants.

Serrao F, Corsello M, Romagnoli C, D'Andrea V, Zecca E.

Breastfeed Med. 2018 Jan/Feb;13(1):67-69. doi: 10.1089/bfm.2017.0169. Epub 2017 Nov 17.

PMID:
29148822
11.

High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial.

Fathalah WF, Abdel Aziz MA, Abou El Soud NH, El Raziky MES.

J Interferon Cytokine Res. 2017 Nov;37(11):480-487. doi: 10.1089/jir.2017.0051.

PMID:
29135373
12.

Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial.

Voroneanu L, Siriopol D, Dumea R, Badarau S, Kanbay M, Afsar B, Gavrilovici C, Covic A.

Int Urol Nephrol. 2017 Dec;49(12):2195-2204. doi: 10.1007/s11255-017-1697-5. Epub 2017 Sep 25.

PMID:
28948420
13.

Bioimpedance analysis, metabolic effects and safety of the association Berberis aristata/Bilybum marianum: a 52-week double-blind, placebo-controlled study in obese patients with type 2 diabetes.

Guarino G, Strollo F, Carbone L, Della Corte T, Letizia M, Marino G, Gentile S.

J Biol Regul Homeost Agents. 2017 Apr-Jun;31(2):495-502.

PMID:
28685558
14.

Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Elyasi S, Shojaee FSR, Allahyari A, Karimi G.

Phytother Res. 2017 Sep;31(9):1323-1329. doi: 10.1002/ptr.5857. Epub 2017 Jun 21.

PMID:
28635153
15.

Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial.

Asgarshirazi M, Shariat M, Sheikh M.

Hepatobiliary Pancreat Dis Int. 2017 Jun;16(3):296-302.

PMID:
28603098
16.

A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.

Wah Kheong C, Nik Mustapha NR, Mahadeva S.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1940-1949.e8. doi: 10.1016/j.cgh.2017.04.016. Epub 2017 Apr 15.

PMID:
28419855
17.

Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD.

Xie Y, Miranda SR, Hoskins JM, Hawke RL.

Molecules. 2017 Jan 15;22(1). pii: E142. doi: 10.3390/molecules22010142.

18.

Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.

Tanwar S, Trembling PM, Hogan BJ, Srivastava A, Parkes J, Harris S, Grant P, Nastouli E, Ocker M, Wehr K, Herold C, Neureiter D, Schuppan D, Rosenberg WM.

Eur J Gastroenterol Hepatol. 2017 Mar;29(3):289-296. doi: 10.1097/MEG.0000000000000789.

PMID:
27906753
19.

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability.

Malaguarnera G, Bertino G, Chisari G, Motta M, Vecchio M, Vacante M, Caraci F, Greco C, Drago F, Nunnari G, Malaguarnera M.

BMC Psychiatry. 2016 Nov 15;16(1):398.

20.

Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.

Elyasi S, Hosseini S, Niazi Moghadam MR, Aledavood SA, Karimi G.

Phytother Res. 2016 Nov;30(11):1879-1885. doi: 10.1002/ptr.5704. Epub 2016 Aug 23.

PMID:
27555604

Supplemental Content

Loading ...
Support Center